Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis type B: prospects for active immunization.

S Krugman

    The American Journal of the Medical Sciences
    |September 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The clinical reaction of Nigerian children to measles vaccine with and without gamma globulin.

    The Journal of hygiene·2010
    Same author

    Epidemiology of Virus Hepatitis [Abridged].

    Proceedings of the Royal Society of Medicine·2009
    Same author

    Postburn itching, pain, and psychological symptoms are reduced with massage therapy.

    The Journal of burn care & rehabilitation·2000
    Same author

    Breastfeeding and IQ.

    Pediatrics·1999
    Same author

    Burn injuries benefit from massage therapy.

    The Journal of burn care & rehabilitation·1998
    Same author

    Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.

    The Journal of infectious diseases·1995
    Same journal

    Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

    The American journal of the medical sciences·2026
    Same journal

    In Memoriam: Maurice A. Mufson, MD, MACP.

    The American journal of the medical sciences·2026
    Same journal

    Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

    The American journal of the medical sciences·2026
    Same journal

    Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

    The American journal of the medical sciences·2026
    Same journal

    Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

    The American journal of the medical sciences·2026
    Same journal

    The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

    The American journal of the medical sciences·2026
    See all related articles

    Heat-activated hepatitis B virus serum is safe, antigenic, and protective, inducing antibodies against the surface antigen. This suggests feasibility for developing inactivated hepatitis B vaccines using purified antigens or polypeptides.

    Area of Science:

    • Virology
    • Immunology
    • Vaccine Development

    Background:

    • Hepatitis B virus (HBV) poses a significant global health challenge.
    • Developing safe and effective HBV vaccines is crucial for prevention.

    Purpose of the Study:

    • To evaluate the safety, antigenicity, and protective potential of a heat-activated hepatitis B virus (MS2 strain) preparation.
    • To explore the feasibility of developing inactivated hepatitis B vaccines.

    Main Methods:

    • Heat activation of serum containing hepatitis B virus (MS2 strain).
    • Active immunization studies in a relevant model.
    • Detection of antibodies to hepatitis B surface antigen (anti-HBs) and core antibody (anti-HBc).

    Main Results:

    Related Experiment Videos

    • The heat-activated HBV preparation was non-infectious.
    • The preparation demonstrated antigenicity and provided protection.
    • Immunization induced anti-HBs without detectable anti-HBc.

    Conclusions:

    • Heat-activated hepatitis B virus serum is a safe and effective candidate for vaccine development.
    • Purified hepatitis B surface antigen or its polypeptides can be used to create inactivated hepatitis B vaccines.